切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2025, Vol. 11 ›› Issue (04) : 331 -336. doi: 10.3877/cma.j.issn.2095-9605.2025.04.011

综述

肥胖背景下乳腺癌肿瘤微环境的变化
卢冠华1,2, 陈嘉宝2, 吴祥慧2, 梁汾梅1,2, 张树3, 陈欣欣1,2,()   
  1. 1510260 广州,广州医科大学附属第二医院乳腺外科
    2510260 广州,广州医科大学第二临床学院
    3200032 上海,复旦大学附属肿瘤医院肿瘤外科
  • 收稿日期:2024-05-20 出版日期:2025-11-30
  • 通信作者: 陈欣欣
  • 基金资助:
    广州医科大学科研能力提升项目; 广州医科大学第二临床学院2024-2025学年度大学生创新创业训练计划项目

Changes in the breast cancer tumor microenvironment in the presence of obesity

Guanhua Lu1,2, Jiabao Chen2, Xianghui Wu2, fenmei Liang1,2, Shu Zhang3, Xinxin Chen1,2,()   

  1. 1Department of Breast Surgery, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510260, China
    2The Second School of Clinical Medicine, Guangzhou Medical University, Guangzhou, 510260, China
    3Department of Surgical oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • Received:2024-05-20 Published:2025-11-30
  • Corresponding author: Xinxin Chen
引用本文:

卢冠华, 陈嘉宝, 吴祥慧, 梁汾梅, 张树, 陈欣欣. 肥胖背景下乳腺癌肿瘤微环境的变化[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(04): 331-336.

Guanhua Lu, Jiabao Chen, Xianghui Wu, fenmei Liang, Shu Zhang, Xinxin Chen. Changes in the breast cancer tumor microenvironment in the presence of obesity[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2025, 11(04): 331-336.

研究已证实肥胖与乳腺癌的发生及发展紧密相连,在肥胖条件下,肿瘤和周围乳腺组织微环境的变化可以促进肿瘤细胞的扩增,增强肿瘤生长和侵袭性特征,导致肥胖乳腺癌患者转移增加和生存率恶化。本综述主要聚焦肥胖背景下的肿瘤微环境中细胞成分以及细胞外基质对乳腺癌生长的影响。

Studies have confirmed that obesity is closely linked to the occurrence and development of breast cancer. Under obesity conditions, changes in the microenvironment of the tumor and surrounding breast tissues can promote the expansion of tumor cells and enhance tumor growth and invasiveness characteristics, leading to increased metastasis and deteriorated survival in breast cancer patients with obesity. This review focuses on the effects of cellular components and extracellular matrix in the tumor microenvironment on breast cancer growth in the presence of obesity.

[1]
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults [J]. Lancet,2017,390(10113):2627-2642.
[2]
Chen K, Shen Z, Gu W, et al. Prevalence of obesity and associated complications in china: a cross-sectional, real-world study in 15.8 million adults [J]. Diabetes Obesity & Metabolism, 2023, 25(11): 3390-3399.
[3]
Xia C, Dong X, Li H, et al. Cancer statistics in china and united states, 2022: profiles, trends, and determinants [J].Chinese Medical Journal, 2022, 135(5): 584-590.
[4]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA: a cancer journal for clinicians, 2021, 71(3): 209-249.
[5]
Zhou S, Zhao Z, Wang Z, et al. Cancer-associated fibroblasts in carcinogenesis [J]. Journal of Translational Medicine, 2025, 23(1): 50.
[6]
Su S, Chen J, Yao H, et al. CD10+ GPR77+ Cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness [J]. Cell, 2018, 172(4): 841-856. e16.
[7]
Demark-Wahnefried W, Rogers LQ, Gibson J T, et al. Randomized trial of weight loss in primary breast cancer: impact on body composition, circulating biomarkers and tumor characteristics [J]. International Journal of Cancer, 2020, 146(10): 2784-2796.
[8]
Balaban S, Shearer RF, Lee LS, et al. Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration [J]. Cancer Metab, 2017, 5: 1.
[9]
Tovar-Hernández K, Salinas-Vera YM, Carlos-Reyes á, et al. Adipocytes reprogram the proteome of breast cancer cells in organotypic three-dimensional cell cultures [J]. Sci Rep, 2024, 14(1): 27029.
[10]
Delort L, Bougaret L, Cholet J, et al. Hormonal therapy resistance and breast cancer: involvement of adipocytes and leptin [J]. Nutrients, 2019, 11(12): 2839.
[11]
Wang T, Fahrmann JF, Lee H, et al. Jak/stat3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance [J]. Cell Metabolism, 2018, 27(1): 136-150.
[12]
Lu H, Clauser KR,Tam WL, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages [J]. Nature Cell Biology, 2014, 16(11): 1105-1117.
[13]
Springer NL, Iyengar NM, Bareja R, et al. Obesity-associated extracellular matrix remodeling promotes a macrophage phenotype similar to tumor-associated macrophages [J]. American Journal of Pathology, 2019, 189(10): 2019-2035.
[14]
Burke RM, Madden KS, Perry SW, et al.Tumor-associated macrophages and stromal tnf-alpha regulate collagen structure in a breast tumor model as visualized by second harmonic generation [J]. Journal of Biomedical Optics, 2013, 18(8): 86003.
[15]
Orlandini LF, Pimentel FF, Andrade JM, et al. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [J]. Brazilian Journal of Medical and Biological Research, 2021, 54(10): e11409.
[16]
Bousquenaud M, Fico F, Solinas G, et al. Obesity promotes the expansion of metastasis-initiating cells in breast cancer [J]. Breast Cancer Research, 2018, 20(1): 104.
[17]
Reggiani F, Labanca V, Mancuso P, et al. Adipose progenitor cell secretion of gm-csf and mmp9 promotes a stromal and immunological microenvironment that supports breast cancer progression [J]. Cancer Research, 2017, 77(18): 5169-5182.
[18]
Okwan-Duodu D, Umpierrez GE, Brawley OW, et al. Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages [J]. American Journal of Cancer Research, 2013, 3(1): 21-33.
[19]
Gibson JT, Orlandella RM, Turbitt WJ, et al. Obesity-associated myeloid-derived suppressor cells promote apoptosis of tumor-infiltrating cd8+ t cells and immunotherapy resistance in breast cancer [J]. Frontiers in Immunology, 2020, 11: 590794.
[20]
Clements VK, Long T, Long R, et al. Frontline science: high fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells [J]. J Leukoc Biol, 2018, 103(3): 395-407.
[21]
Takada K, Kashiwagi S, Asano Y, et al. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy [J]. Bmc Cancer, 2021, 21(1): 1129.
[22]
Neumann S, Campbell K, Woodall MJ, et al. Obesity has a systemic effect on immune cells in naïve and cancer-bearing mice [J]. International Journal of Molecular Sciences, 2021, 22(16): 8803.
[23]
Ali HR, Provenzano E, Dawson SJ, et al. Association between cd8+ t-cell infiltration and breast cancer survival in 12 439 patients [J]. Annals of Oncology, 2014, 25(8): 1536-1543.
[24]
Kado T, Nawaz A, Takikawa A, et al. Linkage of cd8+ t cell exhaustion with high-fat diet-induced tumourigenesis [J]. Sci Rep, 2019, 9(1): 12284.
[25]
Beyer M, Abdullah Z, Chemnitz JM, et al. Tumor-necrosis factor impairs cd4+ t cell-mediated immunological control in chronic viral infection [J]. Nature Immunology, 2016, 17(5): 593-603.
[26]
de Andrade AG, Vanderley S, de Farias ML, et al. Leptin, nk cells, and the weight of immunity: insights into obesity [J]. International Immunopharmacology, 2025, 147: 113992.
[27]
Lee Y, Tukei KL, Fang Y, et al.Obesity alters the vascular morphology and vegf-a signaling in adipose tissue [J]. FASEB Bioadv, 2025, 7(6): e70018.
[28]
Gonzalez-Perez RR, Lanier V, Newman G.Leptin's pro-angiogenic signature in breast cancer [J]. Cancers (Basel), 2013, 5(3): 1140-1162.
[29]
Hillers-Ziemer LE, Arendt LM. Weighing the risk: effects of obesity on the mammary gland and breast cancer risk [J]. J Mammary Gland Biol Neoplasia, 2020, 25(2): 115-131.
[30]
Gu JW,Young E, Patterson SG, et al. Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice [J]. Cancer Biology & Therapy, 2011, 11(10): 910-917.
[31]
Xu J, Ding L, Mei J, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments [J]. Signal Transduct Target Ther, 2025, 10(1): 268.
[32]
Arendt LM, McCready J, Keller PJ, et al. Obesity promotes breast cancer by ccl2-mediated macrophage recruitment and angiogenesis [J]. Cancer Research, 2013, 73(19): 6080-6093.
[33]
Kolb R, Kluz P, Tan ZW, et al. Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4 [J]. Oncogene, 2019, 38(13): 2351-2363.
[34]
Jimenez T, Friedman T, Vadgama J, et al. Nicotine synergizes with high-fat diet to induce an anti-inflammatory microenvironment to promote breast tumor growth [J]. Mediators Inflamm, 2020, 2020: 5239419.
[35]
Sofi S, Jan N, Masoodi G, et al. Combating chemoresistance in breast cancer: exploring tumour microenvironment, combination therapies and drug repurposing strategies [J]. Journal of Drug Targeting, 2025: 1-22.
[36]
Seo BR, Bhardwaj P, Choi S, et al. Obesity-dependent changes in interstitial ecm mechanics promote breast tumorigenesis [J]. Science Translational Medicine, 2015, 7(301): 130r-301r.
[37]
Zhang Y, Baloglu FK, Ziemer L, et al. Factors associated with obesity alter matrix remodeling in breast cancer tissues [J]. Journal of Biomedical Optics, 2020, 25(1): 1-14.
[38]
Conklin MW, Eickhoff JC, Riching KM, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma [J]. American Journal of Pathology, 2011, 178(3): 1221-1232.
[39]
Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling [J]. Cell, 2009, 139(5): 891-906.
[40]
Pastel E, Price E, Sjoholm K, et al. Lysyl oxidase and adipose tissue dysfunction [J]. Metabolism-Clinical and Experimental, 2018, 78: 118-127.
[41]
Hillers-Ziemer LE, Kuziel G, Williams AE, et al. Breast cancer microenvironment and obesity: challenges for therapy [J]. Cancer Metastasis Rev, 2022, 41(3): 627-647.
[42]
Wishart AL, Conner SJ, Guarin JR, et al. Decellularized extracellular matrix scaffolds identify full-length collagen vi as a driver of breast cancer cell invasion in obesity and metastasis [J]. Science Advances, 2020, 6(43): eabc3175.
[1] 潘辰蕊, 杨冰洁, 沈会明, 王颖彦, 韩佳豪, 李嘉. 多模态超声联合免疫炎症指标预测乳腺癌腋窝淋巴结转移的价值[J/OL]. 中华医学超声杂志(电子版), 2025, 22(10): 969-975.
[2] 赵珂欣, 王蓉, 张钧, 杨哲, 石钰环, 姬雅楠, 刘敏丽, 张生军. 雷公藤提取物在三阴性乳腺癌中的作用机制[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(01): 55-59.
[3] 仲洋杨, 邓舒瑶, 李永杰, 李庄. 男性隐匿性乳腺癌一例[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(01): 60-63.
[4] 王伦, 周昕, 宁伟伟, 杨清旭, 胡旭, 何诣航, 谢铭. 我国腹腔镜减重代谢手术后营养不良及管理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 9-11.
[5] 康星, 俞杭, 单晓东, 孙喜太, 褚薛慧. 单孔腹腔镜袖状胃切除术围手术期血液管理措施的比较研究[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 18-21.
[6] 李勇义, 赵均雄, 郭建东, 李文萱, 孟占鳌, 覃杰, 陈涵潇. 瘤体-瘤周细胞外容积模型对前列腺癌的诊断价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 56-64.
[7] 高嘉钰, 张焕磊, 韩发彬. 单细胞测序在髓母细胞瘤微环境及转移复发研究中的应用[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(01): 31-38.
[8] 刘铁鑫, 王震侠. 肿瘤相关成纤维细胞在胰腺导管腺癌中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 124-131.
[9] 唐鑫, 管子龙, 朱爽, 刘方舟, 孙国栋, 王天阳, 石云浩, 齐浩楠, 刘云霄, 王佳琦, 袁子茗, 张巍远, 黄睿. 国产手术机器人与腹腔镜在直肠癌患者术后短期疗效对比分析[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(06): 516-525.
[10] 宋柯瑾, 李文星. 肿瘤相关中性粒细胞在结直肠癌中的双重调控作用及临床意义[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(06): 546-551.
[11] 马博, 李涛, 董扬帆, 商少华, 马华, 王俊, 纪文静. 减重代谢手术改善2型糖尿病肥胖患者胃肠肽及血糖的前瞻性研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 53-60.
[12] 朱风尚, 熊光苏, 韩峻峰. 重视减重多模式组合和个体化治疗[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(06): 561-564.
[13] 肖玉新, 阿衣加马力·衣马木, 热孜亚·艾合买提, 佟钙玉, 邹韶红. 超重/肥胖青少年双相障碍患者的睡眠呼吸障碍与心血管风险特征及相关性分析[J/OL]. 中华临床医师杂志(电子版), 2025, 19(11): 839-847.
[14] 赵莉, 张敏伟, 郭浩东, 于海侠, 王光明, 李德春. 乳腺X线模型构建列线图预测乳腺癌HR及HER2的表达[J/OL]. 中华临床医师杂志(电子版), 2025, 19(10): 747-757.
[15] 刘丹, 张克石, 康清源, 袁平, 关振鹏. 生命早期危险因素暴露与成年期疾病的关系[J/OL]. 中华临床医师杂志(电子版), 2025, 19(07): 520-525.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?